Citigroup Inc Evelo Biosciences, Inc. Transaction History

Citigroup Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$0.17 - $1.57 $16,723 - $154,450	-98,376 Reduced 98.75%	1,249 $0
Q4 2022 Feb 09, 2023	BUY	$1.44 - $2.29 $134,618 - $214,080	93,485 Added 1522.56%	99,625 $160,000
Q3 2022 Nov 10, 2022	BUY	$1.86 - $3.01 $7,826 - $12,666	4,208 Added 217.81%	6,140 $13,000
Q2 2022 Aug 10, 2022	SELL	$1.46 - $3.55 $465 - $1,132	-319 Reduced 14.17%	1,932 $4,000
Q1 2022 May 12, 2022	SELL	$2.66 - $6.63 $18,899 - $47,106	-7,105 Reduced 75.94%	2,251 $8,000

Q4 2021 Feb 10, 2022	BUY	$6.07 - $12.0 $21,936 - $43,368	3,614 Added 62.94%	9,356 $57,000
Q3 2021 Nov 10, 2021	BUY	$6.79 - $13.9 $38,988 - $79,813	5,742 New	5,742 $40,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.